⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
EGCG (Epigallocatechin Gallate)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-10 — Urolithin A plus EGCG enhances mitophagy associated pathways, mitochondrial dynamics, and bioenergetic function in humanized amyloid-β knock-in mice.: [animal-model] A humanized amyloid-beta knock-in mouse study reported improved mitophagy-associated pathways, mitochondrial function, amyloid-beta pathology and cognition with EGCG plus urolithin A; these combination findings do not establish EGCG-alone efficacy or human benefit. [animal-model] (novelty: 3)
- 2026-09-24 — Targeting Glial Glycolysis with EGCG Alleviates Parkinson’s Disease in a PINK1 mutant Drosophila Model.: PINK1-mutant Drosophila Parkinson’s model: EGCG rescued dopaminergic neuron loss and motor deficits by suppressing glial glycolysis and a lactate-driven neuroinflammation axis (animal-model, invertebrate). [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Urolithin A plus EGCG enhances mitophagy associated pathways, mitochondrial dynamics, and bioenergetic function in humanized amyloid-β knock-in mice.
10-nov-2026
novelty 3
per-area 3
strengthens
Mitochondrial-Targeted Phytochemicals in Reproductive Aging: Mechanisms and Translational Potential.
25-sep-2026
novelty 2
per-area 2
introduces
Targeting Glial Glycolysis with EGCG Alleviates Parkinson's Disease in a PINK1 mutant Drosophila Model.
24-sep-2026
novelty 3
per-area 3
strengthens
Reducing Frailty for Older Cancer Survivors Using Supplements II
26-jun-2026
novelty 2
per-area 2
mentions